A review of CpGs and their relevance to aquaculture

Veterinary Immunology and Immunopathology

Volumn 112, Issue 3-4, 2006, Pages 87-101

  Carrington, Allison C ^a   Secombes, Christopher J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Adjuvant; Aquaculture; CpG

Indexed keywords

DNA VACCINE; OLIGODEOXYNUCLEOTIDE;

AMOEBA; ANTIGEN PRESENTING CELL; AQUACULTURE; AUTOIMMUNITY; BACTERIUM; CELL PROLIFERATION; CELL STIMULATION; CPG ISLAND; CYTOKINE RELEASE; FISH; IMMUNE RESPONSE; LEUKOCYTE; LYMPHOCYTE; MACROPHAGE; NONHUMAN; REVIEW; VACCINATION; VIRUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; AQUACULTURE; CELL PROLIFERATION; CYTOKINES; FISH DISEASES; FISHES; IMMUNIZATION; LEUKOCYTES; MACROPHAGE ACTIVATION; OLIGODEOXYRIBONUCLEOTIDES;

BACTERIA (MICROORGANISMS); CYPRINIDAE; MAMMALIA; PISCES; PLEURONECTIFORMES; PROTOZOA; SALMONIDAE;

EID: 33745651083     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2006.03.015     Document Type: Review

References (80)

1. Anderson D.P. Adjuvants and immunostimulants for enhancing vaccine potency in fish. Fish Vaccinology. Dev. Biol. Stand. 90 (1997) 257-265
2. Bauer S., Kirschning C.J., Häcker H., Redecke V., Hausmann S., Akira S., Wagner H., and Lipford G.B. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 9237-9242
3. Brindle A.R., Butler B., and Nowak B.F. Immunostimulatory CpG oligodeoxynucleotides increase resistance against amoebic gill disease in Atlantic salmon, Salmo salar L. J. Fish Dis. 26 (2003) 367-371
4. Carrington A.C., Collet B., Holland J.W., and Secombes C.J. CpG oligodeoxynucleotides stimulate immune cell proliferation but not specific antibody production in rainbow trout (Oncorhynchus mykiss). Vet. Immunol. Immunopathol. 101 (2004) 211-222
5. Corbiel S., Kurath G., and LaPatra S.E. Fish DNA vaccine against infectious hematopoietic necrosis virus: efficacy of various routes of immunisation. Fish Shellfish Immun. 10 (2000) 711-723
6. Corbiel S., LaPatra S.E., Anderson E.D., and Kurath G. Nanogram quantities of a DNA vaccine protect rainbow trout fry against heterologous virus strains of infectious hematopoietic necrosis virus. Vaccine 18 (2000) 2817-2824
7. Dobrovolskaia M.A., and Vogel S.N. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect. 4 (2002) 903-914
8. Frost P., and Ness A. Vaccination of Atlantic salmon with recombinant VP2 infectious pancreatic necrosis virus (IPNV), added to a multivalent vaccine, suppresses viral replication following IPNV challenge. Fish Shellfish Immun. 7 (1997) 609-619
9. Gibson S.J., Lindh J.M., Riter T.R., Gleason R.M., Rogers L.M., Fuller A.E., Oesterich J.L., Gorden K.B., Qiu X., McKane S.W., Noelle R.J., Miller R.L., Kedl R.M., Fitzgerald-Bocarsly P., Tomai M.A., and Vasilakos J.P. Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod. Cell Immunol. 218 (2002) 74-86
10. Gudding R., Lillehaug A., and Evensen Ø. Recent developments in fish vaccinology. Vet. Immunol. Immunopathol. 72 (1999) 203-212
11. Gupta R.K. Aluminum compounds as vaccine adjuvants. Ad. Drug Deliv. Rev. 32 (1998) 155-172
12. Hallman M., Rämet M., and Ezekowitz R.A. Toll-like receptors as sensors of pathogens. Parasitol. Res. 50 (2002) 315-321
13. Heine H., Kirschning C.J., Lien E., Monks B.G., Rothe M., and Golenbock D.T. Cells that carry a null allele for Toll-like receptor 2 are capable of responding to endotoxin. J. Immunol. 162 (1999) 6971-6975
14. Hemmi H., Kaisho T., Takeuchi O., Sato S., Sanjo H., Hoshino K., Horiuchi T., Tomizawa H., Takeda K., and Akira S. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3 (2002) 196-200
15. Heppell J., and Davis H.L. Application of DNA vaccine technology to aquaculture. Ad. Drug Deliv. Rev. 43 (2000) 29-43
16. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., and Akira S. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lpsgene product. J. Immunol. 162 (1999) 3749-3752
17. Jabbari K., Cacci S., Pais de Barros J.P., Desgrrs J., and Bernardi G. Evolutionary changes in CpG and methylation levels in the genome of vertebrates. Gene 205 (1997) 109-118
18. Janeway C.A., and Travers P. Immunobiology-The Immune System In Health And Disease. Current Biology (1997), Churchill Livingstone, Garland
19. Jault C., Pichon L., and Chluba J. Toll-like receptor gene family and TIR-domain adapters in Danio rerio. Mol. Immunol. 40 (2004) 759-771
20. Jørgensen J.B., Johansen A., Stenersen B., and Sommer A.I. CpG oligonucleotide and plasmid DNA stimulate Atlantic salmon (Salmo salar L.) leucocytes to produce supernatants with antiviral activity. Dev. Comp. Immunol. 25 (2001) 313-321
21. Jørgensen J.B., Zou J., Johansen A., and Secombes C.J. Immunostimulatory CpG oligodeoxynucleotides stimulate expression of IL-1ß and interferon-like cytokines in rainbow trout macrophages and the stimulatory effect requires endosomal maturation. Fish Shellfish Immun. 11 (2001) 673-682
22. Jørgensen J.B., Johansen L.-H., Steiro K., and Johansen A. CpG DNA induces protective antiviral immune responses in Atlantic salmon (Salmo salar L.). J. Virol. 77 (2003) 11471-11479
23. Kanellos T.S., Sylvester I.D., Butler V.L., Ambali A.G., and Partidos C.D. Mammalian granulocyte-macrophage colony-stimulating factor and some CpG motifs have an effect on the immunogenicity of DNA and subunit vaccines in fish. Immunology 96 (1999) 507-510
24. Kerkmann M., Rothenfusser S., Hornung V., Towarowski A., Wagner M., Sarris A., Giese T., Endres S., and Hartmann G. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of Type I IFN synthesis in human plasmacytoid dendritic cells. J. Immunol. 170 (2003) 4465-4474
25. Kirschning C.J., Wesche H., Ayres T.M., and Rothe M. Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. Biol. 188 (1998) 2091-2097
26. Klinman D.M., Yamshchikov G., and Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158 (1997) 3635-3639
27. Klinman D.M., Barnhart K.M., and Conover J. CpG motifs as immune adjuvants. Vaccine 17 (1999) 19-25
28. Kollevaag A. Vaccination of salmon-where is the correct injection point?. Intervet Aquat. Anim. Health Newsletter 11 (2005) 2-4
29. Krieg A.M. CpG DNA: a novel immunomodulator. Trends Microbiol. 7 (1999) 64-65
30. Krieg A.M. The role of CpG motifs in innate immunity. Curr. Opin. Immunol. 12 (2000) 35-43
31. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20 (2002) 709-760
32. Krieg A.M., Yi A.-K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., and Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 (1995) 546-549
33. Krieg A.M., Wu T., Weeratna R., Efler S.M., Love-Homan L., Yang L., Yi A.-K., Short D., and Davis H.L. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 12631-12636
34. Krieg A.M., Yi A.-K., Schorr J., and Davis H.L. The role of CpG dinucleotides in DNA vaccines. Trends Microbiol. 6 (1998) 23-27
35. Krieg A.M., Hartmann G., and Yi A.-K. Mechanism of action of CpG DNA. Curr. Top. Microbiol. 247 (2000) 1-21
36. Lee C.H., Jeong H.D., Chung J.K., Lee H.H., and Kim K.H. CpG motif in synthetic ODN primes respiratory burst of olive flounder Paralichthys olivaceus phagocytes and enhances protection against Edwardsiella tarda. Dis. Aquat. Org. 56 (2003) 43-48
37. Lipford G.B., Heeg K., and Wagner H. Bacterial DNA as immune cell activator. Trends Microbiol. 6 (1998) 496-500
38. Lorenzen E., Einer-Jensen K., Martinussen T., LaPatra S.E., and Lorenzen N. DNA vaccination of rainbow trout against viral hemorrhagic septicemia virus: a dose-response and time-course study. J. Aquat. Anim. Health 12 (2000) 167-180
39. Lorenzen N., Lorenzen E., and Einer-Jensen K. Immunity to viral haemorrhagic septicemia (VHS) following DNA vaccitation of rainbow trout at an early life-stage. Fish Shellfish Immun. 11 (2001) 585-591
40. Marshall J.D., Fearon K., Abbate C., Subramanian S., Yee P., Gregorio J., Coffman R.L., and Van Nest G. Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions. J. Leukoc. Biol. 73 (2003) 781-792
41. McCluskie M.J., and David H.L. CpG DNA as mucosal adjuvant. Vaccine 18 (2000) 231-237
42. McLauchlan P.E., Collet B., Secombes C.J., Lorenzen N., and Ellis A.E. DNA vaccination against Viral Haemorrhagic Septicaemia (VHS) in rainbow trout; size, dose, route of injection and duration of protection. Early protection correlates with Mx expression. Fish Shellfish Immun. 15 (2003) 39-50
43. Matzinger P. The danger model: a renewed sense of self. Science 296 (2002) 301-305
44. Means T.K., Lien E., Yoshimura A., Wang S., Golenbock D.T., and Fenton M.J. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J. Immunol. 163 (1999) 6748-6755
45. Medzhitov R., and Janeway Jr. C. The toll receptor family and microbial recognition. Trends Microbiol. 8 (2000) 452-456
46. Meijer A.H., Krens S.F.G., Rodriguez I.A.M., He S., Bitter W., Snaar-Jagalska B.E., and Spaink H.P. Expression analysis of the Toll-like receptor and TIR domain adaptor families of zebrafish. Mol. Immunol. 40 (2004) 773-783
47. Meng Z., Shao J., and Xiang L. CpG oligodeoxynucleotides activate grass carp (Ctenopharyngodon idellus) macrophages. Dev. Comp. Immunol. 27 (2003) 313-321
48. Messina J.P., Gilkeson G.S., and Pisetsky D.S. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J. Immunol. 147 (1991) 1759-1764
49. Midtlyng P.J., Reitan L.J., Lillehaug A., and Ramstad A. Protection, immune responses and side effects in Atlantic salmon (Salmo salar L.) vaccinated against furunculosis by different procedures. Fish Shellfish Immun. 8 (1996) 599-613
50. Mutoloki S., Alexandersen S., and Evensena Ø. Sequential study of antigen persistence and concomitant inflammatory reactions relative to side-effects and growth of Atlantic salmon (Salmo salar L.) following intraperitoneal injection with oil-adjuvanted vaccines. Fish Shellfish Immun. 16 (2004) 633-644
51. Mutwiri G.K., Nichani A.K., Babiuk S., and Babiuk L.A. Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides. J. Control. Release 97 (2004) 1-17
52. Olbrich A.R.M., Schimmer S., and Dittmer U. Preinfection treatment of resistant mice with CpG oligodeoxynucleotides renders them susceptible to friend retrovirus-induced leukemia. J. Virol. 77 (2003) 10658-10662
53. Oshiumi H., Tsujita T., Shida K., Matsumoto M., Ikeo K., and Seya T. Prediction of the prototype of the human Toll-like receptor gene family from the pufferfish, Fugu rubripes, genome. Immunogenetics 54 (2003) 791-800
54. Oumouna M., Jaso-Friedmann L., and Evans D.L. Activation of nonspecific cytotoxic cells (NCC) with synthetic oligodeoxynucleotides and bacterial genomic DNA: binding, specificity and identification of unique immunostimulatory motifs. Dev. Comp. Immunol. 26 (2002) 257-269
55. Pisetsky D.S. Immune activation by bacterial DNA: a new genetic code. Immunity 5 (1996) 303-310
56. Qureshi S.T., Larivière L., Leveque G., Clermont S., Moore K.J., Gros P., and Malo D. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 198 (1999) 615-625
57. Rhodes L.D., Rathbone C.K., Corbett S.C., Harrell L.W., and Strom M.S. Efficacy of cellular vaccines and genetic adjuvants against bacterial kidney disease in chinook salmon (Oncorhynchus tshawytscha). Fish Shellfish Immun. 16 (2004) 461-474
58. Sabroe I., Parker L.C., Wilson A.G., Whyte M.K.B., and Dower S.K. Toll-like receptors: their role in allergy and non-allergic inflammatory disease. Clin. Exp. Allergy 32 (2002) 984-989
59. Schnare M., Holt A.C., Takeda K., Akira S., and Medzhitov R. Recognition of CpG DNA s mediated by signalling pathways dependent on the adaptor protein MyD88. Curr. Biol. 10 (2000) 1139-1142
60. Schwandner R., Dziarski R., Wesche H., Rothe M., and Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274 (1999) 17406-17409
61. Sen G., Flora M., Chattopadhyay G., Klinman D.M., Lees A., Mond J.J., and Snapper C.M. The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity. Cell Immunol. 232 (2004) 64-74
62. Sester D.P., Naik S., Beasley S.J., Hume D.A., and Stacey K.J. Phosphorothioate backbone modification modulates macrophage activation by CpG DNA. J. Immunol. 165 (2000) 4165-4173
63. Singh M., and O'Hagan D.T. Recent advances in vaccine adjuvants. Pharm. Res. 19 (2002) 715-728
64. Spies B., Hochrein H., Vabulas M., Huster K., Busch D.H., Schmitz F., Heit A., and Wagner H. Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice. J. Immunol. 171 (2003) 5908-5912
65. Stafford J.L., Ellestad K.K., Magor K.E., Belosevic M., and Magor B.G. A Toll-like receptor (TLR) gene that is up-regulated in activated goldfish macrophages. Dev. Comp. Immunol. 27 (2003) 685-698
66. Stevenson F.K. DNA vaccines and adjuvants. Immunol. Rev. 199 (2004) 5-8
67. Takeda K., and Akira S. Roles of Toll-like receptors in innate immune responses. Genes Cells 6 (2002) 733-742
68. Tassakka A.C.M.A.R., and Sakai M. CpG oligodeoxynucleotides enhance the non-specific immune responses on carp, Cyprinus carpio. Aquaculture 209 (2002) 1-10
69. Tassakka A.C.M.A.R., and Sakai M. The in vitro effect of CpG-ODNs on the innate immune response of common carp, Cyprinus carpio L. Aquaculture 220 (2003) 27-36
70. Tassakka A.C.M.A.R., and Sakai M. Expression of immune-related genes in the common carp (Cyprinus carpio L.) after stimulation by CpG oligodeoxynucleotides. Aquaculture 242 (2004) 1-12
71. Traxler G.S., Anderson E., LaPatra S.E., Richard J., Shewmaker B., and Kurath G. Naked DNA vaccination of Atlantic salmon Salmo salar against IHNV. Dis. Aquat. Org. 38 (1999) 183-190
72. Van Donkersgoed J., Dixon S., Brand G., and VanderKop M. A survey of injection site lesions in fed cattle in Canada. Can. Vet. J. 38 (1997) 767-772
73. van Drunen Littel-van den Hurk S., Gerdts V., Loehr B.I., Pontarollo R., Rankin R., Uwiera R., and Babiuk L.A. Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals. Ad. Drug Deliv. Rev. 43 (2000) 13-28
74. Verthelyi D., Ishii K.J., Gursel M., Takeshita F., and Klinman D.M. Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs. J. Immunol. 166 (2001) 2372-2377
75. von Beust B.R., Johansen P., Smith K.A., Bot A., Storni T., and Kündig T.M. Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration. Eur. J. Immunol. 35 (2005) 1869-1876
76. Wagne H. The immunobiology of the TLR9 subfamily. Trends Immunol. 25 (2004) 381-386
77. Watson R., and Pauly D. Systematic distortions in world fisheries catch trends. Nature 414 (2001) 534-536
78. Weeratna R.D., McCluskie M.J., Xua Y., and Davis H.L. CpG DNA induces stronger immune responses with less toxicity than other adjuvants. Vaccine 18 (2000) 1755-1762
79. Weiner G.J., Liu H.-M., Wooldridge J.E., Dahle C.E., and Krieg A.M. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 10833-10837
80. Zhao Q., Matson S., Herrera C.J., Fisher E., Yu H., and Krieg A.M. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res. Dev. 3 (1993) 53-66